⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
AbbVie Reports First-Quarter 2026 Financial Results
prnewswire.com
ABBV
Rheumatoid Arthritis Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 75+ Leading Players Wheeling the Therapeutics Landscape
globenewswire.com
UCB
AZN
LLY
PFE
ABBV
REGN
AMGN
BMY
SNY
JNJ
TLRY
Axial Spondyloarthritis Management Market to Reach USD 8.06 Billion by 2035, Driven by Biologic Innovation and Rising Demand for Personalized Care | Future Market Insights (FMI)
accessnewswire.com
ABBV
PFE
AMGN
JNJ
LLY
HRZN
Kestrel Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of KST-6051, a Potential Best-in-Class Pan-KRAS Inhibitor, in Patients with KRAS-driven Malignancies
globenewswire.com
ABBV
PFE
AbbVie Submits Application to FDA for Upadacitinib (RINVOQ®) for Adults and Adolescents with Severe Alopecia Areata
prnewswire.com
ABBV
EvolveImmune Therapeutics Announces Achievement of Preclinical Milestone in Collaboration with AbbVie
globenewswire.com
ABBV
Antibiotic Resistance Market to Grow at 5.4% CAGR Reaching USD 12.72 Billion by 2031, Driven by Rising Drug-Resistant Infections and Antimicrobial Innovation: Mordor Intelligence
globenewswire.com
SNY
ABBV
LLY
PFE
Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight
globenewswire.com
MRK
IPHA
VERU
KURA
INCY
AMGN
PFE
GILD
REGN
AZN
CRSP
BIIB
NTRA
ALLO
KYMR
ADCT
IMUX
CELC
ONON
ABBV
TDOC
BMY
IMVT
GNTX
IMPP
AUTL
Global Biosimulation Market Poised for Phenomenal Expansion at a CAGR of ~17% by 2034 | DelveInsight
globenewswire.com
TMO
PFE
AMGN
ABBV
5WPR and Haute MD Release the 2026 Medical Aesthetics AI Visibility Index, Ranking the Top 25 Brands Dominating AI Search in a $22 Billion Category
prnewswire.com
EL
ABBV
LULU